Challenges in the development and establishment of exosome-based drug delivery systems

被引:214
|
作者
Wang, Jin [1 ]
Chen, Derek [1 ]
Ho, Emmanuel A. [1 ,2 ]
机构
[1] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada
[2] Waterloo Inst Nanotechnol, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Exosomes; Extracellular vesicles; Nanoparticles/nanomedicines; Drug delivery; NANOPARTICLE TRACKING ANALYSIS; MILK-DERIVED EXOSOMES; EXTRACELLULAR VESICLES; CELLULAR UPTAKE; IN-VITRO; CULTURE SUPERNATANT; CEREBRAL-ISCHEMIA; FLOW-CYTOMETRY; HUMAN SALIVA; PACLITAXEL;
D O I
10.1016/j.jconrel.2020.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exosomes are extracellular vesicles released from cells and are characterized by a lipid bilayer membrane encapsulating a variety of biological molecules such as nucleic acids or proteins within the lumen or the lipid-bilayer. Under physiological environments, exosomes mediate cell-to-cell communication and cargo transport. Therefore, exosomes have been explored as drug delivery vehicles for improving therapeutic outcomes. Although recent studies have demonstrated promising advances with exosome-based drug delivery systems, several challenges severely hinder further development of exosomes for clinical applications. This review summarizes and emphasizes some of the technical challenges related to the isolation, characterization, and stability testing of exosomes. More importantly, challenges related specifically to the application of exosomes for drug delivery such as cell-uptake, drug loading, drug release, and in vivo distribution will be examined in this article.
引用
收藏
页码:894 / 906
页数:13
相关论文
共 50 条
  • [41] Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies
    Fu, Wei
    Li, Tingting
    Chen, Hongbo
    Zhu, Shu
    Zhou, Changkai
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases
    Wang, Chenglong
    Xu, Maochang
    Fan, Qingze
    Li, Chunhong
    Zhou, Xiangyu
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (01)
  • [43] Exosome-based targeted RNA delivery for immune tolerance induction in skin transplantation
    Li, Chunmin
    Guo, Fengjie
    Wang, Xueli
    Liu, Dongxu
    Wu, Bolun
    Wang, Fenghua
    Chen, Wen
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2020, 108 (07) : 1493 - 1500
  • [44] Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases
    Chenglong Wang
    Maochang Xu
    Qingze Fan
    Chunhong Li
    Xiangyu Zhou
    AsianJournalofPharmaceuticalSciences, 2023, 18 (01) : 29 - 45
  • [45] Exosome-based cancer diagnostics and therapeutics
    Gho, Yong Song
    CANCER SCIENCE, 2018, 109 : 27 - 27
  • [46] Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells
    Balaraman, Ashok Kumar
    Babu, M. Arockia
    Afzal, Muhammad
    Sanghvi, Gaurav
    Rekha, M. M.
    Gupta, Sofia
    Rana, Mohit
    Ali, Haider
    Goyal, Kavita
    Subramaniyan, Vetriselvan
    Wong, Ling Shing
    Kumarasamy, Vinoth
    REGENERATIVE THERAPY, 2025, 28 : 558 - 572
  • [47] Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application
    Yamashita, Takuma
    Takahashi, Yuki
    Takakura, Yoshinobu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (06) : 835 - 842
  • [48] Exosome-based cancer diagnosis and therapeutics
    Ochiya, Takahiro
    Lim, Sai-Kiang
    CANCER SCIENCE, 2021, 112 : 984 - 984
  • [49] Exosome-based candidates move into the clinic
    Cully, Megan
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (01) : 6 - 7
  • [50] Exosome-based nanoparticles and cancer immunotherapy
    Ye, Jiarong
    Li, Danni
    Jie, Yiting
    Luo, Hongliang
    Zhang, Wenjun
    Qiu, Cheng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179